Great Elm Group, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Great Elm Group, Inc. (GEG) on August 27, 2025. The filing reports the entry into a Material Definitive Agreement involving a private placement of equity securities and the appointment of a new director.
Key Financial Metrics and Transaction Details
The filing details a capital raise transaction rather than periodic financial performance metrics. Key transaction figures include:
- Common Stock Issued: 4,000,000 shares.
- Purchase Price: $2.25 per share (based on the 20-day volume-weighted average price).
- Aggregate Proceeds: $9,000,000.
- Warrants Issued:
- Series A: 1,000,000 shares at $3.50 exercise price (10-year term, exercisable after 1 year).
- Series B: 1,000,000 shares at $5.00 exercise price (10-year term, exercisable after 3 years).
The filing text does not provide updated revenue, profit, cash flow, margin, or debt figures for the company as of this date.
Material Changes and Corporate Governance
As a result of the Securities Purchase Agreement with Woodstead Value Fund, L.P.:
- Board Appointment: Booker Smith was elected to the Board of Directors, effective August 27, 2025. He is considered an independent director.
- Ownership Threshold: The Purchaser is entitled to appoint a director as long as it and its affiliates hold at least 2,000,000 shares of Common Stock.
- Registration Rights: The Company agreed to file a registration statement for the resale of the securities within 150 days of the agreement date.
Outlook, Risks, and Contingencies
The transaction was executed as a private placement exempt from registration under Section 4(a)(2) and Rule 506(b) of Regulation D. The Warrants include limited anti-dilution adjustments. The filing does not contain specific forward-looking guidance, risk factors, or management commentary beyond the terms of the agreement and the press release referenced in Item 8.01.
Investor Verification Checklist
- Verify the impact of the 4,000,000 new shares and 2,000,000 warrant shares on total outstanding share count and potential dilution.
- Confirm the use of the $9,000,000 in proceeds as disclosed in the referenced press release (Exhibit 99.1).
- Monitor the filing of the registration statement for the resale of the Purchaser's securities within the 150-day window.
- Review the full text of the Securities Purchase Agreement and Warrants (to be filed as exhibits to the 10-K) for specific anti-dilution terms and covenants.